QT Sense raises €4M to advance a quantum sensing platform
QT Sense, a deep-tech biotech startup building tools to study living cells, announced it has secured €4 million in funding to accelerate its Quantum Nuova platform, a technology that lets scientists observe cellular processes in real time and reveal biochemical activity linked to disease.
QT Sense raises €4M to advance a quantum sensing platform Deep-tech startup QT Sense has secured €4 million to advance its Quantum Nuova platform, which uses quantum sensing nanodiamonds to observe real-time cellular processes and biochemical activity in living cells. Unlike traditional methods that use static snapshots, Quantum Nuova allows researchers to measure cellular stress and biological changes as they occur, offering deeper insights into disease development and drug responses. The funding will support the platform’s transition from prototype to a deployable discovery tool, with initial applications in colorectal cancer research.
- QT Sense secured €4 million in funding for its Quantum Nuova platform.
- The Quantum Nuova platform uses quantum sensing nanodiamonds to observe living cells in real time.
- This technology allows scientists to detect cellular stress and biological changes as they happen, unlike static snapshot methods.
- The funding will accelerate the platform’s development and be used for cancer research applications.
- QT Sense aims to transform its prototype into a deployable discovery platform for labs and drug discovery programs. Continue reading https://thenextweb.com/news/qt-sense-raises-e4m-to-advance-a-quantum-sensing-platform
No comments yet.
Write a comment